{"id":"W2735558737","doi":"10.1111/1346-8138.13956","title":"Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: Subgroup analyses from a randomized, placebo‐controlled phase 3 trial","year":2017,"lang":"en","type":"article","venue":"The Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"Pfizer","keywords":"Tofacitinib; Medicine; Janus kinase inhibitor; Placebo; Dermatology Life Quality Index; Adverse effect; Internal medicine; Psoriasis; Psoriasis Area and Severity Index; Randomized controlled trial; Dermatology; Gastroenterology; Rheumatoid arthritis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005678218,0.0002887106,0.001965293,0.0001717613,0.000387088,0.0000260408,0.0005701965,0.0002159519,0.0001183638],"category_scores_gemma":[0.0005153352,0.0001350037,0.0006702041,0.00005755972,0.0002740395,0.0001169804,0.0000377739,0.0001288072,0.00001498658],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009714562,"about_ca_system_score_gemma":0.0001649256,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004435719,"about_ca_topic_score_gemma":0.0004879576,"domain_scores_codex":[0.9969629,0.001368411,0.001097982,0.0001678256,0.00006635144,0.0003365043],"domain_scores_gemma":[0.9931665,0.004742496,0.001368479,0.0005171672,0.0001693181,0.00003602327],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.980768,0.001135988,0.0002036911,0.000006881126,0.004477675,0.00001912639,0.003465865,0.0001497632,0.002839723,0.00003304872,0.0002943467,0.0066059],"study_design_scores_gemma":[0.9725243,0.001917335,0.000176298,0.0000351541,0.00292805,0.0001480897,0.0004386934,0.0001254904,0.02048885,0.0002137187,0.0008638945,0.0001401199],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9878081,0.006190755,0.0002885656,0.001519552,0.001299141,0.002610322,0.0002232906,0.000005662861,0.0000546279],"genre_scores_gemma":[0.9975303,0.001726249,0.0000526248,0.00005148193,0.0001468806,0.0002852772,0.00003971113,0.00001571028,0.0001517942],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01764913,"threshold_uncertainty_score":0.5505291,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03964438293804168,"score_gpt":0.3271279445394759,"score_spread":0.2874835616014342,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}